By Staff Reporter
QWAQWA – The decision by U.S. President Donald Trump to cut funding for PEPFAR (the U.S. President’s Emergency Plan for AIDS Relief) and USAID (United States Agency for International Development) has sent shockwaves through South Africa’s healthcare system.
The move is expected to have far-reaching consequences for patients, nurses, and healthcare workers.
With South Africa home to the world’s largest population of people living with HIV—over 8 million individuals relying on treatment—the funding cuts will reduce access to lifesaving HIV services and essential medicines, including antiretroviral therapy (ART) and tuberculosis (TB) treatments.
As part of its contingency plan, the government has reduced clinic visits to twice a year, allowing patients to receive six-month ARV refills to minimize disruptions. However, critics, including the Treatment Action Campaign, argue that this measure could negatively affect newly diagnosed HIV/AIDS patients, who require frequent monitoring to ensure treatment effectiveness.
“There is a high potential for decreased adherence among newly diagnosed patients who need more frequent support. Reduced visits may also make it harder for healthcare providers to detect treatment failures early,” the group warned.
HIV/AIDS activist Grace Mofokeng expressed concerns about increased infection rates and delayed detection of medication resistance.“With fewer clinic visits, there will be delayed detection of treatment failure and fewer opportunities for healthcare providers to monitor patients’ response to medication,” said Mofokeng.
She also noted the reduced opportunities for comprehensive care, including screening for opportunistic infections and counseling services.
Despite these concerns, some patients appreciate the reduced frequency of clinic visits, which allows them to manage their time more efficiently and reduce transportation costs.
“I was thrilled to hear about the reduced clinic visits. Working full-time with only weekends off made it difficult to access medical care. This change is a welcome solution,” said one HIV patient who wished to remain anonymous.
Healthcare worker Suzzie Pillay, whose program depends on PEPFAR and USAID funding, admitted initial concerns about the funding cuts but found reassurance in the Ministry of Health’s response. She now sees the new clinic schedule as a way to better manage workloads and provide more focused care to new patients.
“At first, I was worried about the impact on us and our patients, but the minister’s reassurances were a relief. This change will help us manage our workload better and focus on delivering quality healthcare,” she said.
While the reduction in clinic visits has some benefits, it is crucial to address the needs of newly diagnosed patients and ensure continued access to comprehensive, high-quality care.
